Expertise in
1
conditions

Dr. Amir S. Kamran

Hematology
CAMC Cancer Center
3415 Maccorkle Ave SE, 
Charleston, WV 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Expertise in
1
conditions
CAMC Cancer Center
3415 Maccorkle Ave SE, 
Charleston, WV 

Overview

Amir Kamran is a Hematologist practicing medicine in Charleston, West Virginia.

Dr. Kamran is highly rated in 1 condition, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Anemia, and ALK-Positive Non-Small Cell Lung Cancer.

He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 5 clinical trials. Dr. Kamran is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in WV

Hospital Affiliations

Charleston Area Medical Center
Boone Memorial Hospital
Jackson General Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Dominion National
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

CAMC Cancer Center
3415 Maccorkle Ave SE, Charleston, WV 25304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Procedure, Other
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

30 Total Publications

Erratum to 'Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases' [Seminars in Oncology 53/1 (2026) 152436].
Erratum to 'Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases' [Seminars in Oncology 53/1 (2026) 152436].
Journal: Seminars in oncology
Published: August 12, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

WVU Cancer Institute At Thomas Memorial Hospital

500 Poplar St, 
Charleston, WV 
 (7.1 miles away)
304-766-4350
Languages Spoken:
English, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Narender Jogenpally is a Hematologist practicing medicine in Charleston, West Virginia. Dr. Jogenpally is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Anemia, Upper Tract Urothelial Carcinoma (UTUC), Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jogenpally is currently accepting new patients.

Expertise in
51
conditions
Dr. Galena Salem
Hematology | Oncology
Expertise in
51
conditions
Dr. Galena Salem
Hematology | Oncology
Referral may be required

Kings Daughters Medcial Specialties Inc

617 23rd St Ste 19, 
Ashland, KY 
 (57.6 miles away)
606-325-2221
Languages Spoken:
English, Russian, Ukrainian
See accepted insurances
Accepting New Patients

Galena Salem is a Hematologist and an Oncologist practicing medicine in Ashland, Kentucky. Dr. Salem is highly rated in 51 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Clear Cell Sarcoma, and Bone Marrow Transplant. Dr. Salem is currently accepting new patients.

Expertise in
23
conditions
Dr. Waris A. Waris
Hematology | Oncology
Expertise in
23
conditions
Dr. Waris A. Waris
Hematology | Oncology
Referral may be required

Logan Regional Physician Practices

1690 Holden Rd Fl 1, 
Logan, WV 
 (39.1 miles away)
304-239-8070
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Waris Waris is a Hematologist and an Oncologist practicing medicine in Logan, West Virginia. Dr. Waris is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, Anemia, and Endoscopy. Dr. Waris is currently accepting new patients.

Frequently Asked Questions about Dr. Amir S. Kamran

How do I make an appointment with Dr. Amir S. Kamran?

You can book an appointment with Dr. Amir S. Kamran by calling their office at 304-388-8380. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amir S. Kamran a top-rated expert for Muscle Invasive Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amir S. Kamran is classified as an Advanced expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amir S. Kamran specialize in?

While Dr. Amir S. Kamran is a Hematology, they have specific expertise in Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Amir S. Kamran participate in research or clinical trials?

Yes. Dr. Amir S. Kamran has published 30 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. Amir S. Kamran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amir S. Kamran accept my insurance?

Dr. Amir S. Kamran accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 304-388-8380 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kamran's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile